SEC Form 4 · accession 0001179110-16-018104
CymaBay Therapeutics, Inc. · CBAY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Charles McWherter
Officer — Sr. Vice President
Period of report
Jan 26, 2016
Accepted (ET)
Jan 28, 2016 · 6:10 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001042074
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $1.06 | Jan 26, 2016 | A | 54,000 | A | — | Jan 25, 2026 | Common Stock | 54,000 | 54,000 | D |
Explanation of responses
- F1The option vests with respect to one-quarter of the underlying shares upon the first anniversary of the grant date, and then with respect to the remaining shares monthly thereafter over the next three years.